Corona Remedies Ltd has received the Good Manufacturing Practices (GMP) compliance certification from the Eurasian Economic Union (EAEU) for its Gujarat facility. This achievement validates the company’s adherence to international quality standards, paving the way for expanded market access across EAEU member countries and strengthening its global pharmaceutical credentials.
Corona Remedies Ltd, one of India’s fastest-growing pharmaceutical companies, has announced that its Gujarat manufacturing facility has been awarded the EAEU-GMP certification. This recognition underscores the company’s commitment to maintaining world-class manufacturing standards and positions it strongly for international expansion.
The certification is a significant milestone, as it enhances Corona Remedies’ ability to export medicines to EAEU member states, including Russia, Belarus, Kazakhstan, Armenia, and Kyrgyzstan. It also reinforces the company’s reputation as a trusted player in therapeutic areas such as women’s healthcare, cardio-diabetes, pain management, and urology.
Key Highlights
-
Certification: EAEU-GMP compliance awarded to Gujarat manufacturing facility.
-
Global Access: Enables entry into Eurasian Economic Union markets.
-
Quality Standards: Validates adherence to international manufacturing and safety protocols.
-
Strategic Impact: Strengthens global footprint and export potential.
-
Company Profile: Among India’s top 30 pharma firms, with strong presence in women’s healthcare and pain management.
This achievement reflects Corona Remedies’ long-term vision of expanding its global reach while maintaining excellence in quality and innovation.
Sources: ScanX News, Corona Remedies Official Website, Rediff Money